(Q55475071)

12 July 2018

title

Accelerated radiotherapy with concomitant ACNU/Ara-C for the treatment of malignant glioma. (English)

1 reference

12 July 2018

adaptive radiation therapy

main subject

0 references

author name string

K Anders

1

1 reference

12 July 2018

G G Grabenbauer

2

1 reference

12 July 2018

U Schuchardt

3

1 reference

12 July 2018

R Fahlbusch

4

1 reference

12 July 2018

R Fietkau

5

1 reference

12 July 2018

R Sauer

6

1 reference

12 July 2018

P Krauseneck

7

1 reference

12 July 2018

publication date

1 May 2000

1 reference

12 July 2018

Journal of Neuro-Oncology

published in

1 reference

12 July 2018

volume

48

1 reference

12 July 2018

issue

1

1 reference

12 July 2018

page(s)

63-73

1 reference

12 July 2018

Long-term follow-up results of 175 patients with malignant glioma: importance of radical tumour resection and postoperative adjuvant therapy with interferon, ACNU and radiation

cites work

1 reference

12 December 2020

Combined modality approach to treatment of malignant gliomas--re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group

1 reference

12 December 2020

Improving the acceptability of high-dose radiotherapy by reducing the duration of treatment: accelerated radiotherapy in high-grade glioma

1 reference

12 December 2020

Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors

1 reference

12 December 2020

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

1 reference

12 December 2020

Adjuvant intraarterial chemotherapy with nimustine in the management of World Health Organization Grade IV gliomas of the brain. Experience at the Department of Neurosurgery of Düsseldorf University

1 reference

12 December 2020

Cytosine arabinoside plus cisplatin and other drugs as chemotherapy for gliomas.

1 reference

12 December 2020

Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme

1 reference

12 December 2020

Corticosteroid-induced magnetic resonance imaging changes in patients with recurrent malignant glioma.

1 reference

12 December 2020

Chemotherapy for malignant gliomas

1 reference

12 December 2020

Combination chemotherapy (COMP protocol) and radiotherapy of anaplastic supratentorial gliomas

1 reference

12 December 2020

Clinical pharmacology of l-β-D-arabinofuranosyl cytosine

1 reference

12 December 2020

Pharmacokinetics of a new water-soluble nitrosourea derivative (ACNU) in human gliomas

1 reference

12 December 2020

Preliminary experimental results with the nitrosourea derivative ACNU in the treatment of malignant gliomas.

1 reference

12 December 2020

Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme: a phase II study

1 reference

12 December 2020

A randomized trial of accelerated hyperfractionated radiation therapy and bis-chloroethyl nitrosourea for malignant glioma. A preliminary report of Radiation Therapy Oncology Group 83-02

1 reference

12 December 2020

Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02.

1 reference

12 December 2020

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

12 December 2020

Steroid-induced CT changes in patients with recurrent malignant glioma

1 reference

12 December 2020

Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma

1 reference

12 December 2020

Chemotherapy of malignant gliomas.

1 reference

12 December 2020

Effects of ACNU and radiotherapy on malignant glioma

1 reference

12 December 2020

Advantage of treating anaplastic gliomas with aggressive protocol combining chemotherapy and radiotherapy

1 reference

12 December 2020

Modifying radical radiotherapy in high grade gliomas; shortening the treatment time through acceleration

1 reference

12 December 2020

A model for the chemotherapy of acute leukemia with 1-beta-D-arabinofuranosylcytosine

1 reference

12 December 2020

Phase II study of continuous infusion carmustine and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytoma.

1 reference

12 December 2020

Treatment of high grade glioma xenografts with nitrosoureas in nude mice.

1 reference

12 December 2020

Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02.

1 reference

12 December 2020

Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid

1 reference

12 December 2020

Radiotherapy of glioblastoma multiforme. Feasibility of increased fraction size and shortened overall treatment

1 reference

12 December 2020

Long-term survival in treated anaplastic astrocytomas. A report of combined RTOG/ECOG studies

1 reference

12 December 2020

Chemotherapy response criteria in malignant glioma

1 reference

12 December 2020

Results of three consecutive combined treatments for malignant gliomas. Ten-year experience at a single institution.

1 reference

12 December 2020

A comparison of intraarterial carboplatin and ACNU for the treatment of gliomas.

1 reference

12 December 2020

Adjuvant therapy with dibromodulcitol and BCNU increases survival of adults with malignant gliomas. EORTC Brain Tumor Group

1 reference

12 December 2020

Intra arterial chemotherapy with ACNU and radiotherapy in inoperable malignant gliomas.

1 reference

12 December 2020

Somnolence syndrome in adults following cranial irradiation for primary brain tumours

1 reference

12 December 2020

Clinical results and pharmacokinetics of high-dose cytosine arabinoside (HD ARA-C)

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1006498525605

1 reference

12 July 2018

Dimensions Publication ID

1046510599

0 references

1 reference

12 July 2018